publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
pleas
cite
articl
press
saleh
f
et
al
threedimension
cell
cultur
model
studi
respiratori
syncyti
viru
infect
j
infect
public
health
http
doi
background
respiratori
syncyti
viru
rsv
primari
caus
morbid
mortal
worldwid
affect
infant
young
children
immunecompromis
patient
howev
current
vaccin
avail
prevent
rsv
infect
overwhelm
major
knowledg
rsv
caus
infect
base
upon
studi
carri
use
tradit
method
cell
cultur
flat
plastic
dish
although
simplifi
cultur
system
essenti
gain
insight
fundament
hostpathogen
interact
cell
expos
condit
cell
tissu
bodi
therefor
poor
represent
thein
vivo
microenviron
studi
aim
develop
first
cultur
model
rsv
infect
use
cell
test
util
rsv
pathogenesi
method
gener
spheroid
cell
cultur
use
ultralow
attach
plate
gener
cell
spheroid
viabil
spheroid
assess
trypan
blue
exclus
assay
flow
cytometri
show
promin
live
cell
throughout
spheroid
confirm
high
viabil
seven
day
incub
result
immunostain
spheroid
inocul
rsv
show
timedepend
dissemin
viral
antigen
rsvf
within
spheroid
result
syncytia
format
increas
mucin
secret
compar
uninfect
cell
addit
rsv
success
replic
spheroid
produc
infecti
viru
earli
day
one
postinocul
sustain
day
postinocul
conclus
result
show
spheroid
suscept
permiss
rsv
sinc
exhibit
characterist
rsv
infect
includ
syncytia
format
mucin
overexpress
suggest
spheroid
use
promis
model
studi
rsv
vitro
respiratori
syncyti
viru
rsv
one
major
caus
pediatr
respiratori
tract
infect
rsv
estim
caus
approxim
million
annual
case
among
infant
less
one
million
requir
hospit
recent
shown
rsv
account
influenzalik
ill
lebanon
children
age
year
highest
risk
infect
recurr
infect
later
life
inevit
usual
asymptomat
accompani
mild
symptom
rsv
envelop
pneumoviru
belong
paramyxovirida
famili
linear
nonseg
singlestrand
sens
rna
genom
code
viral
protein
two
envelop
protein
glycoprotein
g
fusion
protein
f
constitut
viral
antigen
trigger
humor
cellular
immun
respons
host
g
protein
mediat
attach
rsv
host
cell
f
protein
trigger
fusion
viral
envelop
cell
plasma
membran
viral
penetr
moreov
f
protein
mediat
fusion
neighbor
cell
result
http
author
publish
elsevi
ltd
behalf
king
saud
bin
abdulaziz
univers
health
scienc
open
access
articl
cc
byncnd
licens
http
syncytia
format
common
method
viru
propag
rsv
infect
start
mild
upper
respiratori
tract
infect
howev
infect
progress
lower
respiratori
tract
infect
character
sever
symptom
pathogenesi
epitheli
cell
necrosi
slough
desquam
cell
bronchiolar
lumen
submucos
adventiti
tissu
edema
well
accumul
macrophag
neutrophil
peribronchiolar
perivascular
region
besid
excess
mucu
secret
syncytia
format
repres
main
hallmark
rsv
infect
excess
mucu
secret
upon
rsv
infect
lead
format
mucu
plug
pulmonari
obstruct
short
breath
data
current
avail
rsv
studi
monolay
cultur
cell
cultur
model
lack
complex
biolog
process
occur
vivo
therefor
pathogenesi
rsv
flat
model
may
repres
happen
vivo
studi
demonstr
cell
undergo
differ
biolog
respons
grown
compar
set
differ
morpholog
alter
cytoskelet
organ
cell
adhes
chang
includ
differ
prolifer
rate
signal
process
differenti
potenti
mani
differ
believ
result
fact
cell
grown
monolay
flat
plastic
surfac
subject
cellcel
cellmatrix
interact
solubl
factor
matrix
composit
stiff
oxygen
nutrient
gradient
protein
concentr
gradient
mechan
stress
would
sourc
tissu
sinc
earli
increas
number
evid
emerg
cell
cultur
remark
recapitul
host
cell
respons
microbi
infect
vivo
cultur
success
studi
variou
virus
first
definit
model
human
noroviru
hepat
c
viru
howev
date
report
investig
rsv
growth
pathogenesi
cultur
studi
scaffoldfre
cultur
system
adopt
use
ultralow
attach
ula
plate
gener
practic
econom
spheroid
model
test
permiss
rsv
african
green
monkey
kidney
cell
vero
cell
atcc
human
alveolar
epitheli
type
ii
cell
atcc
human
laryng
carcinoma
cell
cell
atcc
kind
gift
dr
ralph
tripp
univers
georgia
cultur
dulbecco
modifi
eagl
mediumhigh
glucos
dmem
supplement
fetal
bovin
serum
uml
penicillinstreptomycin
penstrep
biowest
maintain
co
c
cell
cultur
monolay
dissoci
suspend
complet
medium
contain
methylcellulos
thicken
agent
seed
densiti
cell
prepar
l
methylcellulos
nutrit
medium
seed
roundbottom
ultralow
attach
ula
plate
corn
well
form
singl
spheroid
whose
size
vari
depend
initi
cell
seed
densiti
cell
incub
seven
day
media
chang
everi
day
durat
experi
spheroid
growth
viabil
assess
day
postseed
cultur
media
aspir
spheroid
wash
pb
ml
sigma
spheroid
dissoci
singlecel
suspens
treatment
trypsin
edta
ml
sigma
min
follow
gentl
pipet
complet
media
ad
singlecel
suspens
correspond
spheroid
centrifug
rpm
min
cell
pellet
resuspend
l
mixtur
complet
media
trypan
blue
ml
sigma
viabl
cell
count
determin
use
hemocytomet
altern
cell
pellet
resuspend
calceinam
solut
life
technolog
incub
room
temperatur
min
dark
follow
incub
cell
pellet
resuspend
l
pb
pass
guava
flow
cytomet
total
live
event
excit
nm
per
sampl
measur
green
fluoresc
nm
gate
analysi
perform
use
flowjo
flowjo
llc
cytometri
analysi
softwar
repres
densityplot
graph
shown
vero
cell
use
viru
propag
cell
inocul
human
rsv
subgroup
rsva
irr
multipl
infect
moi
viru
harvest
upon
extens
syncytia
format
day
singl
freezethaw
lysi
cycl
follow
centrifug
collect
supernat
viru
stock
quantifi
use
plaqu
assay
brief
cell
seed
plate
inocul
l
serial
dilut
viru
stock
h
gentl
shake
everi
min
afterward
cell
cover
ml
newli
prepar
agaros
nutrit
overlay
incub
day
plaqu
visual
stain
cell
crystal
violet
solut
contain
formaldehyd
threedayold
spheroid
inocul
use
rsv
moi
volum
l
incub
h
allow
viru
adsorpt
inoculum
remov
spheroid
wash
dmem
incub
day
l
dmem
contain
fb
penstrep
plaqu
assay
use
assess
spheroid
infecti
viru
yield
day
postinocul
time
point
five
spheroid
pool
supernat
broken
cell
suspens
vigor
pipet
cell
lyse
flash
freez
ensur
releas
virion
cell
result
cell
lysat
centrifug
plaqu
assay
perform
supernat
shown
determin
viral
yield
term
plaqu
form
unit
pfu
per
millilit
ml
day
postinocul
spheroid
fix
paraformaldehyd
acro
min
permeabil
triton
ml
sigma
pb
min
spheroid
block
block
solut
bsa
g
sigma
triton
pb
h
follow
overnight
incub
mixtur
mous
antirsv
fusion
protein
antibodi
millipor
rabbit
antihuman
antibodi
final
immunostain
spheroid
mount
fluoroshield
dapi
histolog
mount
medium
visual
laser
scan
confoc
microscop
zeiss
fluoresc
intens
rsvf
captur
imag
quantifi
employ
zen
blue
edit
zeiss
present
fold
chang
valu
infect
spheroid
compar
time
match
control
experi
done
least
two
time
triplic
unless
otherwis
indic
data
present
mean
sd
statist
signific
differ
group
perform
student
ttest
use
spss
statist
softwar
version
spss
inc
chicago
il
usa
pvalu
consid
indic
statist
signific
differ
three
start
cellseed
densiti
use
name
cellswel
well
ultralow
attach
ula
plate
fig
result
spheroid
follow
day
cultur
wellform
spheroid
visibl
cell
seed
densiti
day
postseed
becom
compact
day
fig
howev
cell
seed
densiti
fail
produc
wellform
spheroid
even
day
incub
therefor
abandon
cell
count
viabil
spheroid
assess
use
trypan
blue
exclus
assay
fig
three
day
postseed
spheroid
grew
reach
viabl
cell
viabil
cell
spheroid
contain
viabl
cell
viabil
throughout
day
cell
spheroid
maintain
constant
viabl
cell
count
cell
although
viabil
gradual
yet
significantli
decreas
reach
day
fig
cell
spheroid
gradual
signific
declin
viabil
record
throughout
day
viabl
cell
count
significantli
drop
cell
assign
timepoint
spheroid
immunostain
antirsv
f
antibodi
green
antibodi
red
counterstain
nuclear
stain
dapi
blue
visual
confoc
microscopi
magnif
n
syncyti
format
rsv
infect
spheroid
day
postinfect
also
shown
inset
magnif
mucin
accumul
rsvf
dissemin
measur
zeiss
laser
scan
confoc
microscop
mucin
intens
fold
chang
evalu
infect
spheroid
time
match
control
n
rsvf
intens
fold
chang
evalu
day
day
infect
spheroid
n
error
bar
repres
sd
n
p
p
p
day
viabil
compar
viabil
analysi
cell
spheroid
show
significantli
lower
viabil
bigger
spheroid
smaller
one
therefor
spheroid
adopt
rest
studi
viabil
profil
cell
spheroid
valid
use
flow
cytometri
similar
data
obtain
use
trypan
blue
observ
steadi
timedepend
declin
viabil
spheroid
day
healthi
popul
drop
respect
fig
next
sought
determin
spheroid
suscept
permiss
rsv
infect
spheroid
inocul
rsv
moi
immunostain
day
postinocul
fig
promin
rsvf
protein
stain
note
day
postinocul
fig
dissemin
toward
core
spheroid
day
postinocul
fig
mild
syncytia
format
induc
rsv
infect
also
note
spheroid
rim
day
postinocul
fig
inset
intens
rsvf
protein
stain
increas
day
compar
day
postinocul
fig
find
indic
viru
effect
infect
spheroid
spread
toward
center
throughout
infect
addit
increas
express
note
spheroid
day
postinfect
compar
mock
uninfect
product
increas
reach
day
postinocul
rel
mock
fig
result
indic
progress
infect
establish
form
viru
dissemin
within
spheroid
gradual
mucin
accumul
hallmark
rsv
infect
establish
demonstr
success
infect
spheroid
rsv
plaqu
assay
perform
investig
growth
kinet
rsv
spheroid
day
infect
fig
data
reveal
product
viral
replic
spheroid
yield
log
pfuml
unit
day
postinocul
viru
yield
slightli
drop
log
day
reach
log
pfuml
day
postinocul
suggest
spheroid
capabl
sustain
infect
day
postinocul
anim
model
routin
use
studi
rsvinduc
respiratori
diseas
even
though
use
fulli
mimic
viral
pathogenesi
vivo
attribut
molecular
cellular
physiolog
differ
anim
human
cultur
techniqu
use
mani
year
wide
varieti
biomed
applic
rang
cancer
stem
cell
biolog
tissu
engin
regen
medicin
cultur
promot
direct
cellcel
contact
interact
cell
extracellular
matrix
ecm
vivolik
exchang
solubl
factor
thu
allow
cell
close
resembl
vivo
parent
tissu
oppos
monolay
counterpart
despit
success
use
technolog
studi
microbi
infect
still
infanc
cultur
model
well
demonstr
util
studi
bacteri
viral
pathogen
previou
studi
reveal
spheroid
repres
model
pseudomona
aeruginosa
salmonella
enterica
compar
monolay
cultur
term
invas
histopatholog
immunopatholog
cell
grown
spheroid
also
shown
first
definit
model
human
noroviru
hepat
c
viru
studi
lack
suitabl
cell
cultur
murin
studi
model
virus
capabl
replic
trigger
cytopath
effect
spheroid
moreov
influenza
viru
human
immunodefici
viru
hiv
coronaviru
success
studi
cultur
recent
zou
et
al
develop
human
adult
stem
cell
asc
deriv
airway
util
assess
infect
emerg
influenza
virus
human
anoth
work
iml
colleagu
introduc
cultur
primari
human
lymphocyt
ex
vivo
model
system
studi
tissuelik
microenviron
establish
simpl
econom
spheroid
cultur
alveolar
type
ii
epitheli
cell
model
studi
rsv
infect
cultur
model
provid
tool
investig
cellular
molecular
mechan
underli
rsv
pathogenesi
potenti
test
effect
antivir
molecul
syncytia
format
excess
mucin
product
hallmark
rsv
infect
vivo
vitro
monolay
infect
rsv
secret
record
day
start
declin
contrari
studi
perform
monolay
primari
human
airway
epitheli
cell
report
syncytium
format
increas
mucin
product
day
postinfect
result
show
cell
grown
spheroid
suscept
permiss
rsv
dissemin
center
spheroid
induc
excess
mucin
secret
day
postinfect
accompani
syncytia
format
show
cell
spheroid
behav
close
primari
cell
monolay
term
mucin
product
syncytia
format
upon
rsv
infect
furthermor
show
infect
product
day
postinocul
viru
progress
spread
toward
center
spheroid
notabl
viru
yield
drop
day
one
log
pfuml
could
explain
cell
death
happen
core
spheroid
overal
data
clearli
show
spheroid
constitut
promis
model
rsv
infect
studi
knowledg
first
studi
develop
cultur
model
rsv
use
alveolar
epitheli
type
ii
cell
show
infect
spheroid
display
key
featur
rsv
infect
vivo
ie
mucin
secret
therefor
cultur
might
promis
vitro
model
candid
studi
rsv
bridg
gap
monolay
vivo
model
due
permiss
sustain
rsv
infect
abil
recapitul
lung
epitheli
tissu
respons
infect
importantli
cheap
simpl
gener
howev
model
without
limit
lack
vasculatur
tissu
heterogen
fluid
flow
observ
vivo
therefor
work
requir
make
cultur
ideal
model
system
studi
virushost
interact
maxim
translat
util
studi
support
council
scientif
research
lebanon
cnrsl
medic
practic
plan
mpp
fund
american
univers
beirut
lebanon
